Explore strategies with our On-Demand Video featuring breast cancer experts | Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes | 0.5-hour CME/CE | #MedEd #cme #HR+breastcancer | https://bit.ly/495OtG3
PRIME Education’s Post
More Relevant Posts
-
Explore strategies with our On-Demand Video featuring breast cancer experts | Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes | 0.5-hour CME/CE | #MedEd #cme #HR+breastcancer | https://bit.ly/495OtG3
-
-
Explore strategies with our On-Demand Video featuring breast cancer experts | Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes | 0.5-hour CME/CE | #MedEd #cme #HR+breastcancer | https://bit.ly/495OtG3
-
-
Explore strategies with our On-Demand Video featuring breast cancer experts | Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes | 0.5-hour CME/CE | #MedEd #cme #HR+breastcancer | https://bit.ly/495OtG3
-
-
Overview of HER2-Targeting Agents in Breast Cancer and Treatment Selection Approaches 👇 Targeted Oncology provides a comprehensive overview of HER2-targeting agents in breast cancer and considerations to factor into treatment decisions. Read more below 🔗 https://lnkd.in/eFMaB3g5
-
Focusing on HER2+ breast cancer
Focusing on HER2+ breast cancer, Erika P. Hamilton, MD, and the Oncology Brothers review data from JBCRG-M06/EMERALD looking at trastuzumab and pertuzumab in combination with eribulin or a taxane in locally advanced or metastatic disease. #BCSM #ASCO24 https://lnkd.in/eXsdHsD3
Recent Data from JBCRG-M06/EMERALD in HER2+ Breast Cancer
targetedonc.com
-
Recently published in Clinical Cancer Research: A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer https://bit.ly/3BqsTkG #SABCS24
-
-
🎗️ In focus this Pancreatic Cancer Awareness Month: Chemotherapy switch for localised pancreatic cancer: A systematic review and meta-analysis 🔬 These findings shed light on the potential of tailored treatment strategies to improve patient outcomes. 📖 Read the full study here: https://lnkd.in/gQE4e6d5 #PancreaticCancerAwareness #ResearchMatters #PancreaticCancer #CancerResearch
-
-
Expert insights on targeted breast cancer therapies with Aditya Bardia 👉 https://lnkd.in/eDQwvYg7 Can novel therapies improve outcomes for patients with ER+, HER2– breast cancer who progressed on first-line therapy? - Find out in 20 minutes! #BreastCancer #MedEd #GetYourAnswersinCME
Endocrine Sensitivity in the Real World: Practical Guidance to Optimize Second-Line Care in ER-Positive, HER2-Negative Advanced Breast Cancer
d.answersincme.com
-
Experts discuss oral SERDs in the pipeline, clinical pathways for treatment of breast cancer, and strategies to help ensure patients have access to treatment. They also offer perspectives on diverse agents in development, including their toxicity profiles. Watch the #PeerExchange series here: https://bit.ly/3WdkGsj #ManagedCare #BreastCancer
Advances in Therapy for ER+/HER2- Metastatic Breast Cancer
ajmc.com
